story of the week
FOLFOX4 vs Sequential Dose-Dense FOLFOX7 Followed by FOLFIRI in Patients With Resectable Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
FOLFOX4 Versus Sequential Dose-Dense FOLFOX7 Followed by FOLFIRI in Patients With Resectable Metastatic Colorectal Cancer (MIROX): A Pragmatic Approach to Chemotherapy Timing With Perioperative or Postoperative Chemotherapy From an Open-Label, Randomized Phase III Trial
Ann. Oncol 2015 Feb 01;26(2)340-347, M Hebbar, B Chibaudel, T André, L Mineur, D Smith, C Louvet, JL Dutel, M Ychou, JL Legoux, M Mabro, R Faroux, D Auby, D Brusquant, A Khalil, S Truant, A Hadengue, C Dalban, B Gayet, F Paye, FR Pruvot, F Bonnetain, J Taieb, P Brucker, B Landi, M Flesch, E Carola, P Martin, E Vaillant, A de GramontFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.